Global Favipiravir Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Favipiravir Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Favipiravir by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Favipiravir by Country/Region, 2017, 2022 & 2028

2.2 Favipiravir Segment by Type

2.2.1 Original Drug

2.2.2 Generic Drug

2.3 Favipiravir Sales by Type

2.3.1 Global Favipiravir Sales Market Share by Type (2017-2022)

2.3.2 Global Favipiravir Revenue and Market Share by Type (2017-2022)

2.3.3 Global Favipiravir Sale Price by Type (2017-2022)

2.4 Favipiravir Segment by Application

2.4.1 Influenza Viruses

2.4.2 HIV

2.4.3 SARS

2.4.4 Ebola

2.4.5 Other

2.5 Favipiravir Sales by Application

2.5.1 Global Favipiravir Sale Market Share by Application (2017-2022)

2.5.2 Global Favipiravir Revenue and Market Share by Application (2017-2022)

2.5.3 Global Favipiravir Sale Price by Application (2017-2022)

3 Global Favipiravir by Company

3.1 Global Favipiravir Breakdown Data by Company

3.1.1 Global Favipiravir Annual Sales by Company (2020-2022)

3.1.2 Global Favipiravir Sales Market Share by Company (2020-2022)

3.2 Global Favipiravir Annual Revenue by Company (2020-2022)

3.2.1 Global Favipiravir Revenue by Company (2020-2022)

3.2.2 Global Favipiravir Revenue Market Share by Company (2020-2022)

3.3 Global Favipiravir Sale Price by Company

3.4 Key Manufacturers Favipiravir Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Favipiravir Product Location Distribution

3.4.2 Players Favipiravir Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Favipiravir by Geographic Region

4.1 World Historic Favipiravir Market Size by Geographic Region (2017-2022)

4.1.1 Global Favipiravir Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Favipiravir Annual Revenue by Geographic Region

4.2 World Historic Favipiravir Market Size by Country/Region (2017-2022)

4.2.1 Global Favipiravir Annual Sales by Country/Region (2017-2022)

4.2.2 Global Favipiravir Annual Revenue by Country/Region

4.3 Americas Favipiravir Sales Growth

4.4 APAC Favipiravir Sales Growth

4.5 Europe Favipiravir Sales Growth

4.6 Middle East & Africa Favipiravir Sales Growth

5 Americas

5.1 Americas Favipiravir Sales by Country

5.1.1 Americas Favipiravir Sales by Country (2017-2022)

5.1.2 Americas Favipiravir Revenue by Country (2017-2022)

5.2 Americas Favipiravir Sales by Type

5.3 Americas Favipiravir Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Favipiravir Sales by Region

6.1.1 APAC Favipiravir Sales by Region (2017-2022)

6.1.2 APAC Favipiravir Revenue by Region (2017-2022)

6.2 APAC Favipiravir Sales by Type

6.3 APAC Favipiravir Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Favipiravir by Country

7.1.1 Europe Favipiravir Sales by Country (2017-2022)

7.1.2 Europe Favipiravir Revenue by Country (2017-2022)

7.2 Europe Favipiravir Sales by Type

7.3 Europe Favipiravir Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Favipiravir by Country

8.1.1 Middle East & Africa Favipiravir Sales by Country (2017-2022)

8.1.2 Middle East & Africa Favipiravir Revenue by Country (2017-2022)

8.2 Middle East & Africa Favipiravir Sales by Type

8.3 Middle East & Africa Favipiravir Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Favipiravir

10.3 Manufacturing Process Analysis of Favipiravir

10.4 Industry Chain Structure of Favipiravir

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Favipiravir Distributors

11.3 Favipiravir Customer

12 World Forecast Review for Favipiravir by Geographic Region

12.1 Global Favipiravir Market Size Forecast by Region

12.1.1 Global Favipiravir Forecast by Region (2023-2028)

12.1.2 Global Favipiravir Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Favipiravir Forecast by Type

12.7 Global Favipiravir Forecast by Application

13 Key Players Analysis

13.1 Fujifilm Toyama Chemical

13.1.1 Fujifilm Toyama Chemical Company Information

13.1.2 Fujifilm Toyama Chemical Favipiravir Product Offered

13.1.3 Fujifilm Toyama Chemical Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Fujifilm Toyama Chemical Main Business Overview

13.1.5 Fujifilm Toyama Chemical Latest Developments

13.2 CSPC Pharmaceutical Group

13.2.1 CSPC Pharmaceutical Group Company Information

13.2.2 CSPC Pharmaceutical Group Favipiravir Product Offered

13.2.3 CSPC Pharmaceutical Group Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CSPC Pharmaceutical Group Main Business Overview

13.2.5 CSPC Pharmaceutical Group Latest Developments

13.3 Reyoung Pharmaceutical

13.3.1 Reyoung Pharmaceutical Company Information

13.3.2 Reyoung Pharmaceutical Favipiravir Product Offered

13.3.3 Reyoung Pharmaceutical Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Reyoung Pharmaceutical Main Business Overview

13.3.5 Reyoung Pharmaceutical Latest Developments

13.4 Sihuan Pharmaceutical

13.4.1 Sihuan Pharmaceutical Company Information

13.4.2 Sihuan Pharmaceutical Favipiravir Product Offered

13.4.3 Sihuan Pharmaceutical Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sihuan Pharmaceutical Main Business Overview

13.4.5 Sihuan Pharmaceutical Latest Developments

13.5 Hisun Pharm

13.5.1 Hisun Pharm Company Information

13.5.2 Hisun Pharm Favipiravir Product Offered

13.5.3 Hisun Pharm Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hisun Pharm Main Business Overview

13.5.5 Hisun Pharm Latest Developments

14 Research Findings and Conclusion

Table 1. Favipiravir Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Favipiravir Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Original Drug

Table 4. Major Players of Generic Drug

Table 5. Global Favipiravir Sales by Type (2017-2022) & (K Units)

Table 6. Global Favipiravir Sales Market Share by Type (2017-2022)

Table 7. Global Favipiravir Revenue by Type (2017-2022) & ($ million)

Table 8. Global Favipiravir Revenue Market Share by Type (2017-2022)

Table 9. Global Favipiravir Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Favipiravir Sales by Application (2017-2022) & (K Units)

Table 11. Global Favipiravir Sales Market Share by Application (2017-2022)

Table 12. Global Favipiravir Revenue by Application (2017-2022)

Table 13. Global Favipiravir Revenue Market Share by Application (2017-2022)

Table 14. Global Favipiravir Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Favipiravir Sales by Company (2020-2022) & (K Units)

Table 16. Global Favipiravir Sales Market Share by Company (2020-2022)

Table 17. Global Favipiravir Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Favipiravir Revenue Market Share by Company (2020-2022)

Table 19. Global Favipiravir Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Favipiravir Producing Area Distribution and Sales Area

Table 21. Players Favipiravir Products Offered

Table 22. Favipiravir Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Favipiravir Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Favipiravir Sales Market Share Geographic Region (2017-2022)

Table 27. Global Favipiravir Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Favipiravir Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Favipiravir Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Favipiravir Sales Market Share by Country/Region (2017-2022)

Table 31. Global Favipiravir Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Favipiravir Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Favipiravir Sales by Country (2017-2022) & (K Units)

Table 34. Americas Favipiravir Sales Market Share by Country (2017-2022)

Table 35. Americas Favipiravir Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Favipiravir Revenue Market Share by Country (2017-2022)

Table 37. Americas Favipiravir Sales by Type (2017-2022) & (K Units)

Table 38. Americas Favipiravir Sales Market Share by Type (2017-2022)

Table 39. Americas Favipiravir Sales by Application (2017-2022) & (K Units)

Table 40. Americas Favipiravir Sales Market Share by Application (2017-2022)

Table 41. APAC Favipiravir Sales by Region (2017-2022) & (K Units)

Table 42. APAC Favipiravir Sales Market Share by Region (2017-2022)

Table 43. APAC Favipiravir Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Favipiravir Revenue Market Share by Region (2017-2022)

Table 45. APAC Favipiravir Sales by Type (2017-2022) & (K Units)

Table 46. APAC Favipiravir Sales Market Share by Type (2017-2022)

Table 47. APAC Favipiravir Sales by Application (2017-2022) & (K Units)

Table 48. APAC Favipiravir Sales Market Share by Application (2017-2022)

Table 49. Europe Favipiravir Sales by Country (2017-2022) & (K Units)

Table 50. Europe Favipiravir Sales Market Share by Country (2017-2022)

Table 51. Europe Favipiravir Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Favipiravir Revenue Market Share by Country (2017-2022)

Table 53. Europe Favipiravir Sales by Type (2017-2022) & (K Units)

Table 54. Europe Favipiravir Sales Market Share by Type (2017-2022)

Table 55. Europe Favipiravir Sales by Application (2017-2022) & (K Units)

Table 56. Europe Favipiravir Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Favipiravir Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Favipiravir Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Favipiravir Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Favipiravir Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Favipiravir Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Favipiravir Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Favipiravir Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Favipiravir Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Favipiravir

Table 66. Key Market Challenges & Risks of Favipiravir

Table 67. Key Industry Trends of Favipiravir

Table 68. Favipiravir Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Favipiravir Distributors List

Table 71. Favipiravir Customer List

Table 72. Global Favipiravir Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Favipiravir Sales Market Forecast by Region

Table 74. Global Favipiravir Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Favipiravir Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Favipiravir Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Favipiravir Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Favipiravir Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Favipiravir Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Favipiravir Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Favipiravir Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Favipiravir Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Favipiravir Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Favipiravir Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Favipiravir Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Favipiravir Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Favipiravir Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Favipiravir Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Favipiravir Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Favipiravir Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Favipiravir Revenue Market Share Forecast by Application (2023-2028)

Table 92. Fujifilm Toyama Chemical Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors

Table 93. Fujifilm Toyama Chemical Favipiravir Product Offered

Table 94. Fujifilm Toyama Chemical Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Fujifilm Toyama Chemical Main Business

Table 96. Fujifilm Toyama Chemical Latest Developments

Table 97. CSPC Pharmaceutical Group Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors

Table 98. CSPC Pharmaceutical Group Favipiravir Product Offered

Table 99. CSPC Pharmaceutical Group Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. CSPC Pharmaceutical Group Main Business

Table 101. CSPC Pharmaceutical Group Latest Developments

Table 102. Reyoung Pharmaceutical Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors

Table 103. Reyoung Pharmaceutical Favipiravir Product Offered

Table 104. Reyoung Pharmaceutical Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Reyoung Pharmaceutical Main Business

Table 106. Reyoung Pharmaceutical Latest Developments

Table 107. Sihuan Pharmaceutical Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors

Table 108. Sihuan Pharmaceutical Favipiravir Product Offered

Table 109. Sihuan Pharmaceutical Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Sihuan Pharmaceutical Main Business

Table 111. Sihuan Pharmaceutical Latest Developments

Table 112. Hisun Pharm Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors

Table 113. Hisun Pharm Favipiravir Product Offered

Table 114. Hisun Pharm Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Hisun Pharm Main Business

Table 116. Hisun Pharm Latest Developments

List of Figures

Figure 1. Picture of Favipiravir

Figure 2. Favipiravir Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Favipiravir Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Favipiravir Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Favipiravir Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Original Drug

Figure 10. Product Picture of Generic Drug

Figure 11. Global Favipiravir Sales Market Share by Type in 2021

Figure 12. Global Favipiravir Revenue Market Share by Type (2017-2022)

Figure 13. Favipiravir Consumed in Influenza Viruses

Figure 14. Global Favipiravir Market: Influenza Viruses (2017-2022) & (K Units)

Figure 15. Favipiravir Consumed in HIV

Figure 16. Global Favipiravir Market: HIV (2017-2022) & (K Units)

Figure 17. Favipiravir Consumed in SARS

Figure 18. Global Favipiravir Market: SARS (2017-2022) & (K Units)

Figure 19. Favipiravir Consumed in Ebola

Figure 20. Global Favipiravir Market: Ebola (2017-2022) & (K Units)

Figure 21. Favipiravir Consumed in Other

Figure 22. Global Favipiravir Market: Other (2017-2022) & (K Units)

Figure 23. Global Favipiravir Sales Market Share by Application (2017-2022)

Figure 24. Global Favipiravir Revenue Market Share by Application in 2021

Figure 25. Favipiravir Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Favipiravir Revenue Market Share by Company in 2021

Figure 27. Global Favipiravir Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Favipiravir Revenue Market Share by Geographic Region in 2021

Figure 29. Global Favipiravir Sales Market Share by Region (2017-2022)

Figure 30. Global Favipiravir Revenue Market Share by Country/Region in 2021

Figure 31. Americas Favipiravir Sales 2017-2022 (K Units)

Figure 32. Americas Favipiravir Revenue 2017-2022 ($ Millions)

Figure 33. APAC Favipiravir Sales 2017-2022 (K Units)

Figure 34. APAC Favipiravir Revenue 2017-2022 ($ Millions)

Figure 35. Europe Favipiravir Sales 2017-2022 (K Units)

Figure 36. Europe Favipiravir Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Favipiravir Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Favipiravir Revenue 2017-2022 ($ Millions)

Figure 39. Americas Favipiravir Sales Market Share by Country in 2021

Figure 40. Americas Favipiravir Revenue Market Share by Country in 2021

Figure 41. United States Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Favipiravir Sales Market Share by Region in 2021

Figure 46. APAC Favipiravir Revenue Market Share by Regions in 2021

Figure 47. China Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Favipiravir Sales Market Share by Country in 2021

Figure 54. Europe Favipiravir Revenue Market Share by Country in 2021

Figure 55. Germany Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Favipiravir Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Favipiravir Revenue Market Share by Country in 2021

Figure 62. Egypt Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Favipiravir Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Favipiravir in 2021

Figure 68. Manufacturing Process Analysis of Favipiravir

Figure 69. Industry Chain Structure of Favipiravir

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles